Literature DB >> 3941007

Effect of platelet-activating factor (PAF) on human cardiac muscle.

G Alloatti, G Montrucchio, F Mariano, C Tetta, R De Paulis, M Morea, G Emanuelli, G Camussi.   

Abstract

The effect of platelet activating factor (PAF) on three mechanical [maximal mechanical tension (Pmax); time to peak tension; maximal rate of rise of tension (+dP/dt)] and four electrical [action potential duration (APD); resting membrane potential; overshoot; maximum rate of depolarization] parameters of cardiac function was studied on fragments of isolated human cardiac papillary muscle. 20 specimens of small tissue fragments excised from the left ventricle by open heart surgery were challenged with various doses of synthetic PAF (10(-10)-10(-6) M). PAF, but not its biologically inactive 2-lyso-derivative (lyso-PAF), induced a biphasic dose-dependent effect, characterized by a transient positive effect on inotropism (increased Pmax, +dP/dt) and of APD, followed by a marked, prolonged negative effect on both inotropism (decreased Pmax, time to peak tension, +dP/dt) and APD. No changes in resting membrane potential, overshoot and maximum rate of depolarization were detected after PAF challenge. Propranolol (2 X 10(-7) M) completely prevented the positive inotropic effect suggesting a stimulation of beta-receptors, possibly exerted by endogenous catecholamines. Indomethacin (1 X 10(-4) M) did not modify the initial positive effect, but markedly reduced the subsequent negative effect induced by PAF on inotropism. These findings are consistent with the interpretation that the effect of PAF on the inotropism is related to liberation of cyclooxygenase-derived metabolites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941007     DOI: 10.1159/000233953

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  8 in total

1.  Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; R de Paulis; A Comino; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

3.  The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition.

Authors:  G Montrucchio; G Alloatti; F Mariano; E Meda; C Tetta; G Emanuelli; G Camussi
Journal:  Agents Actions       Date:  1987-06

4.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.

Authors:  G L Stahl; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

6.  Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+).

Authors:  A Evangelou; V Kalfakakou; J Benveniste; B Arnoux
Journal:  Biol Trace Elem Res       Date:  1995-10       Impact factor: 3.738

7.  Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria.

Authors:  J Diez; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 8.  Cardiotoxicity during invasive pneumococcal disease.

Authors:  Armand O Brown; Elizabeth R C Millett; Jennifer K Quint; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.